ChartRow logo
ChartRow
Investing Charts
DVA
DaVita Inc.Stock · HealthcareS&P 500 0.0%
$235.47+$1.20 (+0.51%)as of market close, Jul 24, 2026
CompareLLYUNHJNJABBVISRGABT

DVADaVita Inc. stock price, chart and key statistics

Key stats

Price data

Price
$235.47
Change YTD
+105.63%
Next earnings
Aug 4, 2026 · After close
Market cap
15.1B
Enterprise value
23B
Shares outstanding
64.2M
52W low
$101.00
52W high
$239.64
From 52W high
-1.74%
From 52W low
+133.14%
52W range
97%
Beta
0.88

Volume

Rel volume
1.01×
30D volume
777.5K
30D $ vol
173.3M

Fundamentals

Sales (ttm)
13.8B
Sales/share
$215.50
EPS (ttm)
$11.35
FCF (ttm)
1.5B
FCF/share
$23.25
Book value/share
$-11.77
Net margin
5.65%
ROA
4.47%
Current ratio
1.42

Growth (CAGR, ttm) · 10Y

Sales
n/a
Net income
+5.04%
FCF
+6.22%
Shares
-11.03%

Per-share growth (CAGR, ttm) · 10Y

EPS
+17.72%
Sales/share
n/a
FCF/share
+19.39%
Book value/share
n/a
Price
+11.69%
Total return
+11.69%

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)
19.3×
Fwd P/E
13.5×
P/S (ttm)
1.1×
P/FCF (ttm)
10.1×
EV/EBITDA (fy)
8.3×
EV/Sales (ttm)
1.7×
FCF yield (ttm)
9.87%
Buyback yield (ttm)
6.58%
Shareholder yield (ttm)
6.58%

Vs own 10Y history

P/E
77th
P/S
84th
P/B
98th
P/FCF
65th

Bar = where today's multiple sits in DVA's own 10-year range:near a decade-low (cheap)near a decade-high (rich).

Performance

1D
+0.51%
1W
-0.63%
1M
+10.53%
3M
+51.89%
YTD
+105.63%
1Y
+55.61%
5Y
+97.26%

Financial statements

Open full DVA financials →

Related Healthcare

1M
TickerThemePrice1M30D $Vol
LLY
Eli Lilly and Company
Pharmaceuticals$1,196+7.05%3.2B
JNJ
Johnson & Johnson
Pharmaceuticals$263+9.30%2.1B
ABBV
AbbVie Inc.
Biopharma$259+10.36%1.9B
UNH
UnitedHealth Group Incorporated Common Stock (DE)
$421+3.66%2.6B
MRK
Merck & Co. Inc.
Pharmaceuticals$131+8.70%1.3B
TMO
Thermo Fisher Scientific Inc.
Life Sciences$568+15.45%1.1B
AMGN
Amgen Inc.
Biotech$376+7.00%969.4M
ABT
Abbott Laboratories
Medical Devices$103+13.95%1.3B

DaVita Inc. (DVA) trades at $235.47 with a live price and an interactive chart covering 30+ years of daily price history, plus key valuation metrics. ChartRow also publishes DVA's financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full DVA financial statements →